Because obesity, cancer, and aging have numerous interrelationships, the recognition of metformin influence on OPN expression may bring a key that will help to tackle epidemics of obesity, diabetes, and cancer. This evidence concerns the gene SPP1 and obesity due to melanocortin 4 receptor deficiency.